Pete Strong

516 total citations
19 papers, 258 citations indexed

About

Pete Strong is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Pete Strong has authored 19 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Pete Strong's work include Antifungal resistance and susceptibility (10 papers), Respiratory viral infections research (5 papers) and Fungal Infections and Studies (4 papers). Pete Strong is often cited by papers focused on Antifungal resistance and susceptibility (10 papers), Respiratory viral infections research (5 papers) and Fungal Infections and Studies (4 papers). Pete Strong collaborates with scholars based in Japan, United Kingdom and United States. Pete Strong's co-authors include Kazuhiro Ito, Garth Rapeport, Lindsey Cass, Alison D. Murray, Thomas Colley, Amanda Davis, Yasuo Kizawa, Darius Armstrong‐James, Genki Kimura and John Ayrton and has published in prestigious journals such as Scientific Reports, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Pete Strong

19 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pete Strong Japan 9 188 174 75 30 19 19 258
Marie Kirwan United Kingdom 6 276 1.5× 199 1.1× 119 1.6× 45 1.5× 9 0.5× 7 352
Gemma Hayes United Kingdom 7 191 1.0× 164 0.9× 91 1.2× 19 0.6× 3 0.2× 11 240
Tatsuro Hirayama Japan 9 151 0.8× 119 0.7× 24 0.3× 6 0.2× 9 0.5× 42 222
Tomo Mihara Japan 9 253 1.3× 204 1.2× 57 0.8× 7 0.2× 3 0.2× 13 298
Stephen Hood United Kingdom 9 135 0.7× 118 0.7× 46 0.6× 5 0.2× 19 1.0× 20 262
M. Haug United States 5 275 1.5× 309 1.8× 28 0.4× 5 0.2× 6 0.3× 5 368
Katsuji Hirano Japan 5 122 0.6× 112 0.6× 39 0.5× 6 0.2× 3 0.2× 9 160
Bright Ocansey United Kingdom 8 221 1.2× 219 1.3× 14 0.2× 7 0.2× 4 0.2× 18 268
Sabrina Williams United States 5 165 0.9× 122 0.7× 13 0.2× 5 0.2× 10 0.5× 11 215
Lindsey te Brake Netherlands 7 209 1.1× 132 0.8× 10 0.1× 5 0.2× 5 0.3× 19 352

Countries citing papers authored by Pete Strong

Since Specialization
Citations

This map shows the geographic impact of Pete Strong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pete Strong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pete Strong more than expected).

Fields of papers citing papers by Pete Strong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pete Strong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pete Strong. The network helps show where Pete Strong may publish in the future.

Co-authorship network of co-authors of Pete Strong

This figure shows the co-authorship network connecting the top 25 collaborators of Pete Strong. A scholar is included among the top collaborators of Pete Strong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pete Strong. Pete Strong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ito, Kazuhiro, Yasuo Kizawa, Genki Kimura, et al.. (2021). Relationship between anti-fungal effects and lung exposure of PC945, a novel inhaled antifungal agent, in Aspergillus fumigatus infected mice. European Journal of Pharmaceutical Sciences. 163. 105878–105878. 5 indexed citations
2.
Murray, Alison D., Lindsey Cass, Kazuhiro Ito, et al.. (2020). PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections. Journal of Fungi. 6(4). 373–373. 31 indexed citations
3.
Cass, Lindsey, Alison D. Murray, Amanda Davis, et al.. (2020). Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent. Pharmacology Research & Perspectives. 9(1). e00690–e00690. 47 indexed citations
4.
5.
DeVincenzo, John P., Lindsey Cass, Alison D. Murray, et al.. (2020). Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study. The Journal of Infectious Diseases. 225(12). 2087–2096. 27 indexed citations
6.
Colley, Thomas, Genki Kimura, Yasuo Kizawa, et al.. (2019). Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection. Scientific Reports. 9(1). 9482–9482. 26 indexed citations
7.
Colley, Thomas, Cheshta Sharma, Alexandre Alanio, et al.. (2019). Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus. Journal of Antimicrobial Chemotherapy. 74(10). 2950–2958. 11 indexed citations
8.
Pagani, Nicole, Alan Murray, Pete Strong, et al.. (2019). PC945, a novel inhaled azole for treatment of fungal tracheobronchitis post-lung transplantation: a case report. Faculty of 1000 Research Ltd. 8. 4 indexed citations
9.
Rudramurthy, Shivaprakash M., Thomas Colley, Alireza Abdolrasouli, et al.. (2019). In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris. Journal of Antimicrobial Chemotherapy. 74(10). 2943–2949. 30 indexed citations
10.
Cass, Lindsey, Amanda Davis, Alison D. Murray, et al.. (2018). 1335. Safety and Pharmacokinetic Profile of PC786, a Novel Inhibitor of Respiratory Syncytial Virus L-protein Polymerase, in a Single and Multiple-Ascending Dose Study in Healthy Volunteer and Mild Asthmatics. Open Forum Infectious Diseases. 5(suppl_1). S407–S408. 6 indexed citations
11.
Coates, Matthew, Samuel Constant, Song Huang, et al.. (2018). Late therapeutic intervention with a respiratory syncytial virus L‐protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium. British Journal of Pharmacology. 175(12). 2520–2534. 28 indexed citations
12.
Kimura, Genki, Yuto Suzuki, Garth Rapeport, et al.. (2017). Effects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised mice. Mycoses. 60(11). 728–735. 5 indexed citations
13.
Kimura, Genki, Thomas Colley, Garth Rapeport, et al.. (2017). In Vivo Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised Mice. Antimicrobial Agents and Chemotherapy. 61(9). 19 indexed citations
14.
Ito, Kazuhiro, Young‐In Kim, Matthew Coates, et al.. (2016). Anti-Viral Activities of PC786, a Novel Inhibitor of Respiratory Syncytial Virus L-Protein Polymerase. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations
15.
Cass, Lindsey, Kazuhiro Ito, Catherine E. Charron, et al.. (2013). Safety, pharmacokinetic and pharmacodynamic profile of RV568, a narrow spectrum kinase inhibitor, following repeat inhaled dosing in COPD patients. European Respiratory Journal. 42(Suppl 57). 1971–1971. 4 indexed citations
16.
17.
Broadley, Kenneth J., Lindsey Cass, Pete Strong, et al.. (2011). RV1088, A Narrow Spectrum Kinase Inhibitor, Inhibits Steroid Resistant Viral Exacerbations Of Ovalbumin-Induced Allergic Airways Responses In Guinea-Pigs. A1303–A1303. 1 indexed citations
18.
19.
Duax, William L., Vivian Cody, & Pete Strong. (1981). Structure of the asthma drug beclomethasone dipropionate. Acta Crystallographica Section B. 37(2). 383–387. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Kirwan Breakdown of academic impact, for papers by Gemma Hayes Breakdown of academic impact, for papers by Tatsuro Hirayama Breakdown of academic impact, for papers by Tomo Mihara Breakdown of academic impact, for papers by Stephen Hood Breakdown of academic impact, for papers by M. Haug Breakdown of academic impact, for papers by Katsuji Hirano Breakdown of academic impact, for papers by Bright Ocansey Breakdown of academic impact, for papers by Sabrina Williams Breakdown of academic impact, for papers by Lindsey te Brake
Rankless by CCL
2026